drugset / Trial / NCT01445925

Substrate Ablation and Remodelling in Non-paroxysmal Atrial Fibrillation (AF)

NCT01445925

RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators hypothesise that modification of the Atrial Fibrillation (AF) substrate by radiofrequency ablation would improve single procedure success rates for Radio Frequency Ablation (RFA) for Non-paroxysmal AF when compared to that achieved with short-term peri-procedural anti-arrhythmic drug therapy alone.

Timeline

Start
2011-09
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Background Amiodarone Small molecule Oral

Indications